Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-21

Clinical Trial Update: The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial [Phase 2]

View source ↗

Summary

A Phase II randomized trial explored metformin to improve tumor oxygenation in locally advanced cervical cancer, with completion reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Uterine Cervical Neoplasms, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED